Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 320
Titolo Data di pubblicazione Autore(i) File
CLINICAL AND ENDOCRINE EFFECTS OF MEGESTROL-ACETATE IN WOMEN WITH PRETREATED ADVANCED BREAST-CANCER 1-gen-1995 Vicario, G; Celio, L; Bajetta, E; Zampino, Mg; Longhi, A; Buzzoni, R; Botti, C; Bogni, A; Bombardieri, E; Rimassa, L; Laffranchi, A
Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer 1-gen-1995 Colleoni, M; Dibartolomeo, M; Dileo, A; Zilembo, N; Carnaghi, C; Pandolfi, A; Rimassa, L; Artale, S; Bajetta, E
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane 1-gen-1997 Martinetti, A; Bajetta, E; Seregni, E; Zilembo, N; Ferrari, L; Noberasco, C; Massaron, S; Rimassa, L; Bombardieri, E
Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma 1-gen-1998 Bajetta, E; Rimassa, L; Carnaghi, C; Del Vecchio, M; Celio, L; Cassata, A
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors 1-gen-1998 Bajetta, E; Rimassa, L; Carnaghi, C; Seregni, E; Ferrari, L; Di Bartolomeo, M; Regalia, E; Cassata, A; Procopio, G; Mariani, L
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma 1-gen-1998 Bajetta, E; Del Vecchio, M; Mortarini, R; Nadeau, R; Rakhit, A; Rimassa, L; Fowst, C; Borri, A; Anichini, A; Parmiani, G
Effectiveness of precautionary chemotherapy in gastric cancer 1-gen-2000 Rimassa, L; Campagnoli, E; Biancofiore, G
Carcinoma del pancreas 1-gen-2001 Rimassa, Lorenza; Zucali, PAOLO ANDREA
Tumori delle vie biliari 1-gen-2001 Rimassa, L; Carnaghi, C; Campagnoli, E
Differenziazione neuroendocrina nei tumori gastroenteropancreatici non endocrini: implicazioni cliniche 1-gen-2001 Carnaghi, C; Gullo, G; Rimassa, L; Santoro, A
Tumori neuroendocrini 1-gen-2001 Carnaghi, C; Rimassa, L; Garassino, I
Carcinoma del colon-retto 1-gen-2001 Zucali, PAOLO ANDREA; Rimassa, Lorenza; Santoro, Armando
Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer 1-gen-2001 Carnaghi, C; Rimassa, L; Garassino, I; Santoro, A
Neuroendocrine differentiation in solid tumors 1-gen-2002 Carnaghi, C; Rimassa, L; Garassino, I; Gullo, G; Santoro, A
Irinotecan and raltitrexed: an active combination in advanced colorectal cancer 1-gen-2002 Carnaghi, C; Rimassa, L; Garassino, I; Zucali, Pa; Masci, G; Fallini, M; Morenghi, E; Santoro, A
Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer 1-gen-2003 Rimassa, L; Carnaghi, C; Garassino, I; Salvini, P; Ginanni, V; Gullo, G; Morenghi, E; Santoro, A
Metastasis of hepatocellular carcinoma to the heart: A case report and review of the literature 1-gen-2004 Masci, G; Magagnoli, M; Grimaldi, A; Covini, G; Carnaghi, C; Rimassa, L; Santoro, A
Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer 1-gen-2004 Magagnoli, M; Masci, G; Castagna, L; Rimassa, L; Bramanti, S; Santoro, A
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 1-gen-2005 Carnaghi, C; Chiti, A; Rimassa, L; Rodari, M; Tronconi, Mc; Zuradelli, M; Marcon, I; Santoro, A
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 1-gen-2005 Carnaghi, Cv; Chiti, A; Marzo, K; Rodari, M; Rimassa, L; Tronconi, Mc; Santoro, A
Mostrati risultati da 1 a 20 di 320
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile